Keywords: seroxat, 1st, major, market, panic, smithkline, beecham

Seroxat In 1st Major Market For Panic

Article | 27 November 1995

Print This

SmithKline Beecham's selective serotonin reuptake inhibitor Seroxat (paroxetine) has been granted a license in the UK for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in